Diversity of disorders causing neonatal cholestasis - the experience of a tertiary pediatric center in Germany

Rapidly establishing the cause of neonatal cholestasis is an urgent matter. The aim of this study was to report on the prevalence and mortality of the diverse disorders causing neonatal cholestasis in an academic center in Germany. Clinical chemistry and cause of disease were retrospectively analyze...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in pediatrics Vol. 2; p. 65
Main Authors: Hoerning, André, Raub, Simon, Dechêne, Alexander, Brosch, Michelle N, Kathemann, Simone, Hoyer, Peter F, Gerner, Patrick
Format: Journal Article
Language:English
Published: Switzerland Frontiers Media S.A 01-01-2014
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Rapidly establishing the cause of neonatal cholestasis is an urgent matter. The aim of this study was to report on the prevalence and mortality of the diverse disorders causing neonatal cholestasis in an academic center in Germany. Clinical chemistry and cause of disease were retrospectively analyzed in 82 infants (male n = 42, 51%) that had presented with neonatal cholestasis to a tertiary medical center from January 2009 to April 2013. Altogether, 19 disorders causing neonatal cholestasis were identified. Biliary atresia was the most common diagnosis (41%), followed by idiopathic cases (13%), progressive familial intrahepatic cholestasis (PFIC, 10%), cholestasis in preterm infants (10%), α1AT deficiency, Alagille syndrome, portocaval shunts, mitochondriopathy, biliary sludge (all 2%), and others. Infants with biliary atresia were diagnosed with a mean age of 62 days, they underwent Kasai portoenterostomy ~66 days after birth. The majority of these children (~70%) received surgery within 10 weeks of age and 27% before 60 days. The 2-year survival with their native liver after Kasai procedure was 12%. The time span between Kasai surgery and liver transplantation was 176 ± 73 days. Six children (7%), of whom three patients had a syndromic and one a non-syndromic biliary atresia, died prior to liver transplantation. The pre- and post-transplant mortality rate for children with biliary atresia was ~12 and ~17%, respectively. Neonatal cholestasis is a severe threat associated with a high risk of complications in infancy and it therefore requires urgent investigation in order to initiate life saving therapy. Although in the last 20 years new causes such as the PFICs have been identified and newer diagnostic tools have been introduced into the clinical routine biliary atresia still represents the major cause.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
This article was submitted to Pediatric Gastroenterology and Hepatology, a section of the journal Frontiers in Pediatrics.
Edited by: Andrew S. Day, University of Otago Christchurch, New Zealand
Reviewed by: Pietro Vajro, University of Salerno, Italy; Randolph P. Matthews, The Children’s Hospital of Philadelphia Research Institute, USA; Scott Nightingale, John Hunter Children’s Hospital, Australia
ISSN:2296-2360
2296-2360
DOI:10.3389/fped.2014.00065